Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x

FOSUN Aktie

 >FOSUN Aktienkurs 
0.516 EUR    +3.3%    (Tradegate)
Ask: 0.515 EUR / 9521 Stück
Bid: 0.495 EUR / 9899 Stück
Tagesumsatz: 8633 Stück
Realtime Kurs von 7:30 bis 22 Uhr!
FOSUN Aktie über LYNX handeln
>FOSUN Performance
1 Woche: -1,0%
1 Monat: -4,5%
3 Monate: -15,4%
6 Monate: +5,3%
1 Jahr: -7,6%
laufendes Jahr: -5,8%
>FOSUN Aktie
Name:  FOSUN INTL LTD
Land:  Hong Kong (China)
Sektor:  Mischkonzerne
ISIN/ Wkn:  HK0656038673 / A0MVLL
Symbol/ Ticker:  FNI (Frankfurt)
Kürzel:  FRA:FNI, ETR:FNI, FNI:GR
Index:  -
Webseite:  https://www.fosun.com/
Profil:  Fosun International Ltd. is a diversified multinat..
>Volltext..
Marktkapitalisierung:  4146.88 Mio. EUR
Unternehmenswert:  33163.02 Mio. EUR
Umsatz:  21319.46 Mio. EUR
EBITDA:  1918.7 Mio. EUR
Nettogewinn:  -520.73 Mio. EUR
Gewinn je Aktie:  -0.06 EUR
Schulden:  27812.27 Mio. EUR
Liquide Mittel:  8080.52 Mio. EUR
Operativer Cashflow:  3194.69 Mio. EUR
Bargeldquote:  0.28
Umsatzwachstum:  -17.63%
Gewinnwachstum:  -640.55%
Dividende je Aktie:  -
Dividendenrendite:  0.43%
Dividendenschätzung:  0.43%
Div. Historie:  11.06.25 - 0.0022088€
12.06.24 - 0.0041967197€
>weitere anzeigen...
Insiderhandel:  -
Suchwörter:  FOSUN
Letzte Datenerhebung:  21.12.25
>FOSUN Kennzahlen
Aktien/ Unternehmen:
Aktien: 8129.69 Mio. St.
Frei handelbar: 26.06%
Leerverk. Aktien: -
Rückkaufquote: 0.45%
Mitarbeiter: 104000
Umsatz/Mitarb.: 0.22 Mio. EUR
Analysten:
Analystenrating: Neutral
Kursziel: 15.05%
Bewertung:
KGV: -
KGV lG: 22.27
KUV: 0.19
KBV: 0.3
PEG-Ratio: -
EV/EBITDA: 17.28
Rentabilität:
Bruttomarge: 27.34%
Gewinnmarge: -2.44%
Operative Marge: 3.02%
Managementeffizenz:
Gesamtkaprendite: -0.57%
Eigenkaprendite: -3.63%
>FOSUN Peer Group

Es sind 21 Aktien bekannt.
 
22.12.25 - 02:03
Fosun International Honored with TVB′s Highest Accolade, "Outstanding ESG Award" (PR Newswire)
 
HONG KONG, Dec. 21, 2025 /PRNewswire/ -- On 19 December 2025, the TVB ESG Awards 2025 Presentation Ceremony, hosted by Television Broadcasts Limited ("TVB"), was held at the Hong Kong Convention and Exhibition Center. Fosun International was honored with the highest accolade, the......
19.12.25 - 12:01
Fosun Bets a Halted Alzheimer′s Drug Just Might Work (Bloomberg)
 
GV-971 targets microbes in the gut....
18.12.25 - 11:30
Fosun, BYD Forge Global Strategic Partnership to Lead New 'Mobility + Vacation' Ecosystem (AAStocks)
 
FOSUN INTL (00656.HK) and BYD COMPANY (01211.HK) clinched a global long-term strategic partnership. Based on their core strengths in green mobility, smart manufacturing, tourism and vacation, and family consumption ecosystems, both parties will engage in deep collaboration across all brand matrices to co-build a “Mobility ......
18.12.25 - 01:45
Lagging in the weight-loss market? Take Fosun′s GLP-1 pill (Bamboo Works)
 
Playing catch-up in the anti-obesity business, Pfizer has bought global rights to an oral weight-loss drug from Fosun Pharma in another big licensing deal Key Takeaways:    By Molly Wen It's becoming a familiar story: the Chinese drugs industry has signed another licensing deal with Big Pharma to fast track a weight-loss treatment. This time..... The post Lagging in the weight-loss market? Take Fosun's GLP-1 pill appeared first on Bamboo Works....
15.12.25 - 13:24
Fosun Plans to Buy Maker of Controversial Alzheimer′s Drug (Bloomberg)
 
Shanghai Fosun Pharmaceutical Group Co. announced plans to acquire a controlling stake in a Chinese company that developed the country's first indigenous therapy for Alzheimer's disease only to wind up later suspending sales and production....
09.12.25 - 14:24
Pfizer Signs License Deal With Fosun Unit for Weight-Loss Drug (Bloomberg)
 
Pfizer Inc. has entered into an exclusive global collaboration and licensing deal with a unit of Shanghai Fosun Pharmaceutical (Group) Co. for an early-stage weight-loss drug....
09.12.25 - 13:18
Pfizer Inks About $2 Bln Exclusive Deal With Fosun′s YaoPharma To For Novel GLP-1 Obesity Therapy (AFX)
 
NEW YORK CITY (dpa-AFX) - Pfizer, Inc. (PFE) announced Tuesday it has inked an exclusive global collaboration and license agreement with YaoPharma, a subsidiary of global healthcare company Shangh......
02.12.25 - 11:33
Finloop and FinChain Launch Asia′s First Comprehensive Technical Solution for Japanese Stock Tokenization (PR Newswire)
 
HONG KONG, Dec. 2, 2025 /PRNewswire/ -- Finloop Finance Technology Holding Limited ("Finloop"), a global one-stop Web5 wealth technology platform, and FinChain, both incubated by Fosun Wealth Holdings jointly announced the launch of Asia's first comprehensive technical solution for "Japan......
25.11.25 - 09:12
Beauty market aglow: young Chinese splurge on self-care, Fosun-backed firm says (SCMP)
 
Young Chinese consumers, including a growing number of men, are splurging on aesthetic medical treatments for physical, emotional and social wellness, according to the CEO of Fosun Pharma‑backed Sisram Medical and its subsidiary Alma, who says Asia's relatively low penetration offers greater growth potential than North America. “It is a global trend that younger generations, including those [in mainland China] and Hong Kong, are turning to energy-based aesthetic treatments such as lasers as a......
21.11.25 - 02:03
Fosun International Honored as "ESG Leading Enterprise" by Bloomberg Businessweek/Chinese Edition (PR Newswire)
 
HONG KONG, Nov. 20, 2025 /PRNewswire/ -- On 19 November, the 7th "ESG Leading Enterprises 2025" ceremony, co-organized by Bloomberg Businessweek/Chinese Edition and Deloitte, a globally renowned accounting firm, was successfully held in Hong Kong. The event was honored to feature a......
19.11.25 - 05:06
Chinese Firm Bought Insurer For CIA Agents As Part Of Trillion Dollar Spending Spree (ZeroHedge)
 
Chinese Firm Bought Insurer For CIA Agents As Part Of Trillion Dollar Spending Spree For years, Washington assumed that China's outbound investment flowed mainly into developing economies hungry for infrastructure money. But as scrutiny tightens across the West, it's becoming clear that Beijing's financial reach extended far deeper into wealthy nations - and far earlier - than most policymakers realized. One early warning came in 2016, when Jeff Stein, a veteran journalist covering U.S. intelligence agencies, received an unusual tip: Wright USA, a small insurer that specialized in providing liability coverage for FBI and CIA personnel, had quietly been acquired the year before by Fosun Group, a Chinese conglomerate with reported ties to Beijing's leadership. “Someone with direct knowledge called me up and said, 'Do you know that the insurance company that insures intelligence personnel is owned by the Chinese?'” Stein recalls. “I was astonished.” The concern was immediate and obv...
11.11.25 - 08:36
Guo Guangchang: Fosun Strengthens Globalization Capabilities, Accelerates Innovation through Open Cooperation (PR Newswire)
 
HONG KONG, Nov. 11, 2025 /PRNewswire/ -- On 8 November, Guo Guangchang, Chairman of Fosun International, attended the 3rd Pujiang Biopharmaceutical Original Innovation Conference 2025. During the conference, Guo Guangchang stated, "At this crucial juncture today, China's pharmaceutical......
07.11.25 - 02:03
Fosun International Honored with Gold Award and Best Sustainability Team at The Asset Corporate Sustainability Leadership Awards 2025 (PR Newswire)
 
HONG KONG, Nov. 6, 2025 /PRNewswire/ -- On the evening of 6 November 2025, The Asset, a renowned Asian financial magazine, hosted "The Asset Corporate Sustainability Leadership Awards 2025" ceremony in Singapore. Fosun International Limited ("Fosun International" or the "Company") (HKEX......
07.11.25 - 00:36
Fosun brings UK particle therapy to mainland China in advanced cancer care push (SCMP)
 
Fosun Pharmaceutical, a leading healthcare group, has taken a substantial step towards introducing particle therapy systems to hospitals in mainland China, aligning with Beijing's efforts to make advanced medical treatment accessible to cancer patients across the country. The Shanghai-based company, a subsidiary of China's non-state-owned conglomerate Fosun International, formed a partnership with Leo Cancer Care on Thursday, pledging to distribute the UK firm's Marie medical facilities in the......
06.11.25 - 07:30
Fosun Marks Eighth Year at CIIE, Guo Guangchang Calls for More Cutting-Edge Innovation (PR Newswire)
 
HONG KONG, Nov. 6, 2025 /PRNewswire/ -- On 5 November 2025, the 8th China International Import Expo (CIIE) opened at the National Exhibition and Convention Center (Shanghai). As a "full-attendance" exhibitor for eight consecutive years, Fosun, together with its overseas member companies......
06.11.25 - 04:00
Chairman Guo Guangchang: FOSUN INTL to Harness Global Industrial Advantages to Drive Frontier Innovation in CN (AAStocks)
 
FOSUN INTL (00656.HK) is participating in the China International Import Expo (CIIE) for eight years in a row. The company, alongside its overseas member enterprises and global partners, is showcasing innovative pharmaceuticals, high-end medical devices, and international collaboration achievements at the FOSUN PHARMA (02196.HK)......
28.10.25 - 02:30
IPO: JOYSON ELEC IPO Starts Tdy w/ Entry Fee HKD11,919; CCB, FOSUN INTL Subsidiaries as Cornerstone Investors (AAStocks)
 
JOYSON ELEC (00699.HK) (600699.SH), a smart automotive technology solutions provider listed on the Shanghai Stock Exchange, has announced its IPO details in Hong Kong.The company plans to offer 155.1 million H-shares globally, with the Hong Kong public offering accounting for 10% (15.51 million shares) and the international offe......
21.10.25 - 05:39
KKR, Portugals Quadrantis to buy minority stake in Fosun-owned Peak Reinsurance (Reuters EN)
 
Um den gesamten Artikel unter investing.com zu lesen, klicken Sie bitte auf die Überschrift...
21.10.25 - 03:09
Peak Re Welcomes KKR and Quadrantis Capital as Minority Investors (Business Wire)
 
HONG KONG--(BUSINESS WIRE)--Peak Reinsurance Company Limited (“Peak Re” or the “Company”) and KKR, a leading global investment firm, today announced that funds managed by KKR and Quadrantis Capital have entered into definitive agreements to acquire minority stakes in Peak Re via Peak Reinsurance Holdings Limited. Upon completion, KKR and Quadrantis Capital are expected to hold approximately 11.27% and approximately 1.80% of Peak Re's issued share capital, respectively, with the remaining approximately 86.71% continuing to be held by the majority shareholder, Fosun International Limited. Prudential Financial, Inc. (“Prudential”), which indirectly held an approximate 13.07% minority stake, has divested its stake in Peak Re following the signing of definitive agreements by funds managed by KKR and Quadrantis Capital. This strategic partnership will reinforce Peak Re's commitment to serving its global clientele, underpinned by strong ring-fencing arrangements and robust corporate governance stan...
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Kaum einer, der heute die moderne Medizin kritisiert, wäre ohne sie noch am Leben. - Dr. Gerhard Kocher
Partner:    >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!